April 7, 2017 / 10:48 AM / 3 months ago

BRIEF-Biotest comments on Business Combination Agreement with Creat

1 Min Read

April 7 (Reuters) - Biotest AG:

* Biotest AG, Tiancheng International Investment Limited, Hong Kong, and Blitz 17-623 AG (in future: Tiancheng (Germany) Pharmaceutical Holdings AG), affiliated companies controlled by Creat Group Corporation, have signed a Business Combination Agreement today

* Management board and supervisory board welcome and support takeover offer

* Biotest and Creat view transaction as an opportunity to further develop company Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below